Understanding The Immune Environment in Metastatic Melanoma

Project Details

Collaborators

A/Prof Michael Kershaw, Immune Innovation Laboratory Peter MacCallum Cancer Centre
A/Prof Phil Darcy,  Immune Innovation Laboratory Peter MacCallum Cancer Centre  
A/Prof Paul Neeson, Haematology and Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre

Funding

Funded by grant from Peter MacCallum Foundation and philanthropic support

Research Outcomes

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
Beavis PA, Slaney CY, Kershaw MH, Gyorki D, Neeson PJ, Darcy PK.
Semin Immunol. 2016 Feb;28(1):64-72. doi: 10.1016/j.smim.2015.11.003. Review.

The delicate balance of melanoma immunotherapy.
Gyorki DE, Callahan M, Wolchok JD, Ariyan CE.
Clin Transl Immunology. 2013 Aug 9;2(8):e5. doi: 10.1038/cti.2013.5. Review.
PMID: 25505953

Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.
Gyorki DE, Yuan J, Mu Z, Zaidi B, Pulitzer M, Busam K, Brady MS, Coit DG, Allison JP, Wolchok JD, Ariyan CE.
Ann Surg Oncol. 2013 Sep;20(9):3106-11. doi: 10.1245/s10434-013-2999-1.

Research Group

HONORARY APPOINTMENTS’ RESEARCH PROJECTS



Faculty Research Themes

Cancer

School Research Themes

Cancer in Medicine



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Surgery

Unit / Centre

HONORARY APPOINTMENTS’ RESEARCH PROJECTS